Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • medicine

    Tag: medicine

    You Searched For "medicine"
    Mylan, Pfizer say Mylan-Upjohn combined entity to be known as Viatris

    Mylan, Pfizer say Mylan-Upjohn combined entity to be known as Viatris

    Medical Dialogues Bureau16 Nov 2019 9:20 AM IST
    New Delhi: Mylan N.V. and Pfizer Inc. recently announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn,...
    AIOCD threatens to Boycott CIPLA if it enters into E-Pharmacy Business

    AIOCD threatens to Boycott CIPLA if it enters into E-Pharmacy Business

    Farhat Nasim31 Aug 2019 2:35 PM IST
    New Delhi: A lobby of 8.5 lakh chemists across the country is planning to boycott the products manufactured by Cipla if the company enters the e...
    Stop use of trademark deceptively similar to Glaxo antibiotic Augmentin: Delhi High Court to AFDIL

    Stop use of trademark deceptively similar to Glaxo antibiotic Augmentin: Delhi High Court to AFDIL

    Farhat Nasim29 Jun 2019 11:56 AM IST
    The court's order came on a plea by Glaxo Group Ltd which sought to restrain AFDIL from advertising, marketing or in any manner doing business under...
    Global forum to examine use of safer nicotine products

    Global forum to examine use of safer nicotine products

    Farhat Nasim10 Jun 2019 9:00 AM IST
    The forum will examine the rapidly developing science in relation to nicotine and its use, including policy and regulatory responses.New Delhi: Amid a...
    Washington: Drugmakers will have to reveal medicine prices in TV ads

    Washington: Drugmakers will have to reveal medicine prices in TV ads

    Medical Dialogues Bureau10 May 2019 9:10 AM IST
    Health and Human Services Secretary Alex Azar said the Trump administration has finalized regulations that will require drug companies to disclose...
    DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5

    DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5

    Meghna A Singhania6 May 2019 11:23 AM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    Zydus Cadila gets final USFDA nod for Leflunomide tablets to treat arthritis

    Zydus Cadila gets final USFDA nod for Leflunomide tablets to treat arthritis

    Farhat Nasim26 April 2019 12:49 PM IST
    Leflunomide tablet is used to treat rheumatoid arthritis, a condition affecting multiple small and large joints of the body.New Delhi: Drug firm Zydus...
    Government to ban export of anti-rabies vaccine; Bharat Biotech biz likely to take hit : Report

    Government to ban export of anti-rabies vaccine; Bharat Biotech biz likely to take hit : Report

    Meghna A Singhania7 April 2019 11:00 AM IST
    New Delhi: Hyderabad based biotechnology firm, Bharat Biotech is likely to face setback as the Government plans to impose a ban on export of...
    Pfizer, GSK consumer healthcare venture to focus on China, US market

    Pfizer, GSK consumer healthcare venture to focus on China, US market

    Farhat Nasim7 April 2019 9:14 AM IST
    LONDON: The United States and China will be key focuses for the consumer healthcare venture being formed by GlaxoSmithKline and Pfizer, as the...
    Pfizer gets EU nod to VIZIMPRO for treating lung cancer

    Pfizer gets EU nod to VIZIMPRO for treating lung cancer

    Farhat Nasim6 April 2019 9:40 AM IST
    New Delhi: Pfizer Inc. recently announced that the European Commission has approved VIZIMPRO (dacomitinib), a tyrosine kinase inhibitor (TKI), as...
    Prices of 21 New Drugs fixed by NPPA; Details

    Prices of 21 New Drugs fixed by NPPA; Details

    Meghna A Singhania4 April 2019 10:00 AM IST
    The NPPA order is likely to affect drug majors including Torrent Pharma, Alkem Laboratories, Zydus Pharmaceuticals, Cadila Healthcare, Mylan, Cipla,...
    Novartis division resubmits USFDA application for biosimilar Pegfilgrastim

    Novartis division resubmits USFDA application for biosimilar Pegfilgrastim

    Farhat Nasim4 April 2019 9:15 AM IST
    New Delhi: Novartis division, Sandoz, recently announced resubmission of its Biologics License Application (BLA) for a proposed biosimilar...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok